The US FDA has granted approval for AbbVie’s Epkinly to treat adult patients with relapsed or refractory (R/R) follicular ...

Experts from Sharp offer insights into sustainable practices in pharma packaging, highlighting advancements achieved and ...

Eleva’s CEO says CHO cell line alternatives could become common in therapeutic protein manufacturing, as large molecule drugs become complex and harder to produce at scale.

The US Patent and Trademark Office (USPTO) has granted a patent to Genprex for the use of its Reqorsa gene therapy ...

Insmed has received approval from the EC for Brinsupri to treat NCFB in patients aged 12 and above with two or more ...

At two upcoming events, experts will offer practical solutions to key challenges for oncology and rare disease clinical ...

Merus and Halozyme have signed a worldwide non-exclusive partnership and licence agreement for subcutaneous formulation of ...

Johnson & Johnson has signed a definitive agreement for the acquisition of Halda Therapeutics (Halda) in a deal valued at ...

The FDA’s verdict on Poherdy comes amid Perjeta creator Genentech’s patent infringement lawsuit against Organon and Shanghai ...

A CHMP panel has recommended the high-dose version’s approval, countering an FDA rejection for the drug in recent months.

Medicxi will use the €500m kitty to continue supporting drug hunters and entrepreneurs in creating asset-focused ...

Sarepta has received US FDA approval for updated prescribing information for Elevidys, an AAV-based gene transfer therapy.